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AcmA, which comprises 3 LysM motifs and determines non-
covalent binding to the cell wall peptidoglycan. Both fused 
proteins, i.e. 6HisxCjaAx3LysM and 6HisxCjaDx3LysM, were 
able to bind to nontreated or TCA-pretreated  L. salivarius 
cells.  Conclusion: Our results documented that the LysM-
mediated binding system allows us to construct GEM parti-
cles that present 2  C. jejuni antigens.  © 2015 S. Karger AG, Basel 
 Introduction 
 Campylobacter spp. is a leading cause of zoonotic en-
teric bacterial infections in most developed and develop-
ing nations. In developing countries, campylobacteriosis 
predominates as a pediatric disease, with an extremely 
high incidence rate ( ∼ 40,000–60,000 per 100,000 popu-
lation) in children under 5 years of age [Coker et al., 
2002; Jones et al., 2007]. The incidence rate of campylo-
bacteriosis is lower in developed countries such as the 
USA or European Union (EU) countries (20–100 per 
100,000 population), occurring mainly as sporadic cases 
in young adults and infants [Jones et al., 2007]. The num-
ber of reported confirmed cases of human campylobac-
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 Abstract 
 Background: Food poisoning and diarrheal diseases contin-
ue to pose serious health care and socioeconomic problems 
worldwide.  Campylobacter spp. is a very widespread cause 
of gastroenteritis. Over the past decade there has been in-
creasing interest in the use of lactic acid bacteria (LAB) as 
mucosal delivery vehicles. They represent an attractive op-
portunity for vaccination in addition to vaccination with at-
tenuated bacterial pathogens.  Methods: We examined the 
binding ability of hybrid proteins to nontreated or trichloro-
acetic acid (TCA)-pretreated LAB cells by immunofluores-
cence and Western blot analysis.  Results: In this study we 
evaluated the possibility of using GEM (Gram-positive en-
hancer matrix) particles of  Lactobacillus salivarius as a bind-
ing platform for 2 conserved, immunodominant, extracyto-
plasmic  Campylobacter jejuni proteins: CjaA and CjaD. We 
analyzed the binding ability of recombinant proteins that 
contain  C. jejuni antigens (CjaA or CjaD) fused with the pro-
tein anchor (PA) of the  L. lactis  peptidoglycan hydrolase 
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teriosis in the EU was 220,209 in 2011, which represent-
ed an increase of 2.2% compared to 2010. The EU notifi-
cation rate was 50.28 per 100,000 population in 2011. 
However, as reported by the European Food Safety Au-
thority (EFSA), there is considerable underascertain-
ment and underreporting of the incidence of human 
campylobacteriosis; the true number of disease cases 
may range between 2 million and 20 million per year. 
The principal reservoirs of  Campylobacter  spp. are the 
alimentary tracts of wild and domesticated birds and 
mammals. There are multiple pathways for human expo-
sure to the pathogen, including food, untreated drinking 
water, and contact with surface water or animals. Among 
these sources, broiler meat is unquestionably the main 
source of human infections due to the high levels of con-
sumption by people. The occurrence of  Campylobacter 
 in broiler flocks in the EU in 2011 was high but varied 
widely among countries, ranging from 0 to 92.0% [EFSA, 
2011; EFSA and ECDC, 2013]. According to the scien-
tific opinion of the EFSA Panel on Biological Hazards, 
the handling, preparation, and consumption of under-
cooked broiler meat may account for 20–30% of human 
cases of campylobacteriosis, and 50–80% of human cases 
may be attributed to the chicken reservoir as a whole. It 
is estimated that reducing the numbers of  Campylobacter 
 in poultry intestines by 3 log 10 units at the time of slaugh-
ter would reduce the public health risk by at least 90%. 
Reducing the numbers of  Campylobacter  on the carcass-
es by 1 log 10 unit would reduce the public health risk by 
between 50 and 90% [EFSA, 2011]. Thus, the transmis-
sion of  Campylobacter from poultry to humans is a seri-
ous public health concern. The prevention of human in-
fections requires control measures at all stages of the 
food chain, from agricultural production on the farm to 
the processing, manufacture, and preparation of foods in 
both commercial establishments and the domestic envi-
ronment. However, the main challenge is to develop an 
effective strategy to reduce the level of poultry stock in-
fections. Given that the currently available biosecurity 
interventions appear to have limited effectiveness or are 
difficult to sustain, the most efficient strategy to decrease 
the number of human  Campylobacter  infections may be 
to implement an immunoprophylactic method, i.e. the 
protective vaccination of chickens. While it is known 
that maternal antibodies protect young chickens against 
 Campylobacter colonization, there is no commercial vac-
cine against  Campylobacter available to date [Cawthraw 
and Newell, 2010; Sahin, et al., 2003]. Due to the enor-
mous genetic diversity observed among  C. jejuni/C. coli 
strains, vaccination with live attenuated  Campylobacter 
strains or using killed, whole-cell  Campylobacter  appears 
to be ineffective. Additionally, an effective chicken vac-
cine should induce a rapid and strong immune response, 
yet due to the short life span of broiler chickens the birds 
should be immunized during the first week of life when 
the avian immune system is immature. A recent test of 
subunit vaccines that consisted of conserved  Campylo-
bacter  antigens delivered by attenuated  Salmonella 
strains,  Eimeria or nanoparticles, generated promising 
results [Annamalai et al., 2013; Buckley et al., 2010; Clark 
et al., 2012; Layton et al., 2011; Łaniewski et al., 2012; 
Wyszyńska et al., 2004]. Several detailed reviews reca-
pitulating recent approaches to control  Campylobacter 
in poultry via vaccination have been published within the 
last 5 years [Curtiss et al., 2007; de Zoete et al., 2007; Ja-
gusztyn-Krynicka et al., 2009; Lin, 2009]. Lactic acid bac-
teria (LAB), which constitute a very heterogeneous group 
of Gram-positive, nonsporulating, low-GC-content mi-
croorganisms that are ubiquitous in many nutrient-rich 
environments, represent an attractive alternative for vac-
cinations that employ attenuated bacterial pathogens be-
cause their use eliminates the potential risk of increased 
virulence in young or immunocompromised individu-
als. Moreover, the mucosal administration of rLAB 
strains stimulates both systemic and mucosal immune 
responses against foreign antigens while only inducing a 
low-level immune response against the carrier strains 
[Bahey-El-Din, 2012; Bermudez-Humaran et al., 2011; 
Pontes et al., 2011; Wells and Mercenier, 2008]. In addi-
tion to using live LAB cells, nonliving trichloroacetic acid 
(TCA)-pretreated LAB cells (GEM particles – Gram-
positive enhancer matrix) that are deprived of some sur-
face components and intracellular content can also con-
stitute a safe and efficient vaccine delivery vector for het-
erologous proteins [Audouy et al., 2007; Bosma et al., 
2006; van Roosmalen et al., 2006]. There are 2 strategies 
used to present heterologous antigens on the surface of 
LAB cells. The first approach makes use of the C-termini 
of cell-anchoring proteins that contain the LPXTG rec-
ognition motif. This mechanism requires processing by 
a sortase for covalent anchoring of the protein to the cell 
wall peptidoglycan [Call and Klaenhammer, 2013; 
Schneewind and Missiakas, 2012]. The second approach 
is based on the protein anchor (PA) domain of some lac-
tococcal proteins, such as AcmA. AcmA is the major au-
tolysin of  Lactococcus lactis that is required for cell sepa-
ration and is responsible for cell lysis during the station-
ary phase of growth [Buist et al., 1997]. The autolysin 
contains 3 domains: the N-terminal signal sequence, an 
active site domain, and a C-terminal peptidoglycan-
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binding domain (PA). The PA comprises 3 LysM motifs, 
each with about 45 amino acids, separated by spacer se-
quences. After secretion, AcmA is directed to the cell wall 
and its C-terminus determines its noncovalent binding 
to the cell wall peptidoglycan [Buist et al., 2008]. It has 
been demonstrated that hybrid PA fusions exhibit simi-
lar properties [Bosma et al., 2006; Raha et al., 2005; Steen 
et al., 2003]. Also LysM domains of other Gram-positive 
bacteria bind heterologous proteins to the cell wall pep-
tidoglycan [Hu et al., 2010; Turner et al., 2004; Xu et al., 
2011].
 This work consists of an attempt to evaluate the pos-
sibility of using GEM particles of  Lactobacillus salivarius 
 as a binding platform for 2 conserved, immunodominant, 
extracytoplasmic  Campylobacter  proteins: CjaA (Cj0982c 
in the genome of  C. jejuni  NCTC11168) and CjaD (Cj0113 
in the genome of  C. jejuni NCTC11168). Both proteins 
have been intensively studied as chicken vaccine candi-
dates [Buckley et al., 2010; Clark et al., 2012; Layton et al., 
2011; Łaniewski et al., 2012; Wyszyńska et al., 2004].
 Materials and Methods 
 Bacterial Strains, Primers, Plasmids, Media, and Growth 
Conditions 
 The bacterial strains, plasmids, and primers used in this study 
are listed in  tables 1 and  2 .  L. lactis  IL1403 and L. salivarius  IBB3154 
were used in this study. The  L. salivarius IBB3154 belongs to the 
Regional Strains and Plasmids Collection of the IBB PAS (Institute 
of Biochemistry and Biophysics, Polish Academy of Sciences). The 
 L. lactis  IL1403 strain was routinely cultured at 30  °  C in M17 broth 
(Oxoid) containing 0.5% (weight/volume) glucose (GM17). The 
L. salivarius  strain was cultured in MRS liquid or MRS agar (so-
lidified with 1.5% agar) medium (Difco Laboratories, Detroit, 
Mich., USA) at 37  °  C. The  E. coli strain TG1 was used as a host for 
the construction of recombinant plasmids. The  E. coli strain Ro-
setta (DE3) LysS was used to overexpress pUWM1320 and 
pUWM1292, and the  E. coli strain BL21 (DE3) was used to over-
express pUWM1282 and pUWM1146 [Łaniewski et al., 2014]. 
 C. jejuni and  E. coli strains were grown under standard conditions 
[Łaniewski et al., 2014] unless otherwise indicated. When needed, 
media were supplemented with antibiotics at the following con-
centrations: 100 μg·ml − 1 ampicillin, 30 μg·ml − 1 kanamycin, and 
20 μg·ml − 1 chloramphenicol, as well as Campylobacter Selective 
Supplement (Oxoid) and IPTG (3 mg·ml –1 ) in DMF (dimethylfor-
mamide).
 General DNA Manipulations 
 Standard DNA manipulations were carried out as described 
earlier by Sambrook and Russel [2001] or according to the manu-
facturer’s instructions (A&A Biotechnology, Poland). The chro-
mosomal DNA of  C. jejuni 81–176 and  L. lactis used for PCR reac-
tions were isolated using a commercial kit and protocol (A&A Bio-
technology). PCR were performed with PrimeStar HS DNA 
Polymerase (TaKaRa) or HotStar HiFidelity Polymerase (Qiagen) 
under standard conditions. Synthetic oligonucleotide synthesis 
and DNA sequencing for cloning experiments were performed by 
Genomed S.A., Warsaw, Poland. DNA sequencing of the PCR 
product spanning the 16S rDNA gene was performed by the DNA 
Sequencing and Oligonucleotide Synthesis Service at IBB PAS in 
 Table 1.  Bacterial strains and plasmids used in this study
Strain or plasmid Relevant phenotype(s) or genotype(s) Source or reference(s)
Strains
L. lactis subsp. lactis IL1403 Plasmid-free strain INRA; Chopin et al., 1984
E. coli TG1 supE44 hsdΔ5 thiΔ (lac-proAB) F’ [traD36 proAB+ lacIq lacZΔM15] Sambrook and Russel, 2001
E. coli (DE3) BL21 F– ompT hsdSB (rB– mB–) gal dcm (DE3) Novagen
E. coli Rosetta LysS (DE3) F– ompT hsdSB (rB– mB–) gal dcm (DE3) pLysSRARE (CamR) Novagen
L. salivarius IBB3154 Isolated from chickens This study
C. jejuni 81–176 Wild type; isolated from a child with bloody diarrhea during an 
 outbreak in the USA; pVir, pTet (TcR); Lior 5; Penner 23/26
Korlath et al., 1985
Plasmids
pGEM-T Easy ApR; T vector for cloning PCR products Promega
pET28 KmR; lacI; overexpression vector Novagen
pUWM1146 pelBSS-cjaA-6xhis fusion in pET22b Łaniewski et al., 2014
pUWM1288 cjaA-lysM fusion in pGEM-T Easy This study
pUWM1313 6xhis-cjaA-lysM fusion in pET28a This study
pUWM1290 cjaD in pGEM-T Easy This study
pUWM1292 6xhis-cjaD fusion  in pET28a This study
pUWM1287 cjaD-lysM fusion in pGEM-T Easy This study
pUWM1282 6xhis-cjaD-lysM fusion in pET28a This study
D
ow
nl
oa
de
d 
by
: 
19
8.
14
3.
55
.1
 - 
9/
14
/2
01
5 
3:
04
:3
3 
PM
 Kobierecka   et al. J Mol Microbiol Biotechnol 2015;25:1–10
DOI: 10.1159/000368780
4
Warsaw, using the sequencer ABI377 (Applied Biosystems), and 
then the nucleotide sequences were analyzed using BLAST against 
the nucleotide database on the NCBI website. 
 Construction of Recombinant Plasmids for Recombinant 
Protein Overexpression 
 A CjaD expression vector was made as follows. The  cjaD cod-
ing sequence (without the signal sequence, amino acids 1–18) was 
amplified from  C. jejuni 81–176 chromosomal DNA with the 
primers Cj0148BamHI and Cj0148RXhoI and cloned into pGEM-
T Easy (Promega, Madison, Wisc., USA). Thereafter, the resulting 
plasmid, i.e. pUWM1290, was digested with XhoI and BamHI re-
striction enzymes and a 0.5-kb DNA fragment was inserted into 
pET28a, generating plasmid pUWM1292. The construction of the 
CjaA expression vector (pUWM1146) has been described previ-
ously [Łaniewski et al., 2014].
 The CjaA-LysM (pUWM1320) and CjaD-LysM (pUWM1282) 
expression vectors were constructed via a 2-step PCR method. 
Briefly, the primers LysMF and LysMRXhoI were used to amplify 
the DNA region encoding the C-terminal portion of AcmA (ami-
no acids 211–439) from the chromosome of  L. lactis IL1403. 
CjaANheI-CjaALysM and Cj0148Nhe-Cj0148LysM were used to 
amplify the  cjaA and  cjaD genes, respectively, from the chromo-
some of  C. jejuni 81–176. The CjaALysM and Cj0148LysM prim-
ers contained 5 ′ leader nucleotide sequences complementary to 
LysMF. Each PCR product was purified using a Gel-Out extraction 
kit (A&A Biotechnology). Next, a mixture of 2 purified products 
(in equal amounts) was used as a template in a single PCR reaction, 
using the primers CjaANheI-LysMF or Cj0148Nhe-LysMF to am-
plify  cjaA-lysM and  cjaD-lysM, respectively. The resulting PCR 
products were purified and cloned into pGEM-T Easy to generate 
pUWM1288 and pUWM1277, respectively. Finally, using XhoI 
and NheI restriction enzymes, the 1.5-kb DNA region encoding 
CjaALysM and the 1.1-kb DNA fragment encoding CjaDLysM 
were transferred into pET28b in the native orientation, generating 
pUWM1320 and pUWM1282, respectively. Correct construction 
of the plasmids was verified by sequencing. Protein production 
was confirmed by Western blot using a previously obtained rabbit 
polyclonal anti-rCjaD or anti-rCjaA serum [Łaniewski et al., 2012; 
Pawelec et al., 2000]. All recombinant plasmids encode proteins 
with a 6His tag fused to their N-terminus to allow purification by 
affinity chromatography.
 Overexpression and Purification of CjaA, CjaD, CjaALysM, 
and CjaDLysM 
 CjaDLysM and CjaA were overexpressed and purified from 
 E. coli BL21 harboring pUWM1282 and pUWM1146, respective-
ly. CjaD and CjaALysM were overexpressed and purified from 
 E.  coli  Rosetta (DE3) LysS harboring pUWM1292 and 
pUWM1320, respectively. Expression of CjaD and CjaDLysM 
was induced with 0.5 m M IPTG at OD 600 nm of  ∼ 0.6 from cells 
growing at 18  °  C. CjaA and CjaALysM were overexpressed by au-
toinduction as described by Studier [2005]. After 24 h, cultures 
were centrifuged and cell pellets were suspended in 50 m M sodi-
um phosphate (pH 8.0), 300 m M NaCl, and 10 m M imidazole. 
Cells were disrupted by sonication. Subsequently, the cell lysates 
were centrifuged and the resulting supernatants were applied 
onto a HisTrap column (Novagen). The proteins were eluted with 
an imidazole gradient. Fractions containing CjaD, CjaA, 
 CjaDLysM, or CjaALysM were pooled and loaded onto a PD-10 
column (GE Healthcare) equilibrated with 50 m M sodium phos-
phate (pH 8.0) and 150 m M NaCl. Overexpression and all purifi-
cation steps were monitored via SDS-PAGE.
 SDS-PAGE and Western Blotting 
 SDS-PAGE and Western blotting procedures were done using 
standard techniques. Blots were developed with nitro blue tetrazo-
lium chloride/5-bromo-4-chloro-3-indolyl phosphate (Sigma-Al-
drich) as a substrate using previously obtained rabbit polyclonal 
anti-rCjaA or anti-rCjaD serum [Łaniewski et al., 2012; Pawelec et 
 Table 2.  Oligonucleotides used in this study
Name Sequence (5′→3′) Orientation/restriction site
Cj0148NheI ACTGCGCTAGCTGTAGCACAAAAAGCACTAGC Forward/NheI
Cj0148LysM GAAGAAGCACCGTCAAAACGAGTTCTTGATAATTTAAATTCAG Reverse/Ø
Cj0148RXhoI GCCTCGAGTTATCTTGATAATTTAAATTCAG Reverse/XhoI
Cj0148BamHI CCGGATCCTGTAGCACAAAAAGCACTAGC Forward/BamHI
LysMF ACTCGTTTTGACGGTGCTTCTTC Forward/Ø
LysMRXho ACCTCGAGTTATTTAATACGAAGATATTG Reverse/XhoI
CjaANheI ACTGCGCTAGCGGAGGAAATTCTGACTC Forward/NheI
CjaALysM GCACCGTCAAAACGAGTAATTTTTCCACCTTCAATCAC Reverse/Ø
16-1A GAATCGCTAGTAATCG Forward/Ø
23-1B GGGTTCCCCCATTCGGA Reverse/Ø
343F TACGGGAGGCAGCAG Forward/Ø
1406R ACGGGCGGTGTGTRC Reverse/Ø
 Restriction enzyme recognition sites introduced for cloning purposes are underlined. All primers were designed on the basis of the 
C. jejuni 81–176 and L. lactis IL1403 genome nucleotide sequences. Bold letters indicate nucleotides complementary to the C. jejuni 
81–176 chromosome nucleotide sequence. The oligos in italics were designed for overlap PCR to construct the cjaA-lysM and cjaD-lysM 
fusion genes.
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al., 2000] or anti-His antibodies (Sigma-Aldrich) as primary anti-
bodies and mouse anti-rabbit IgG alkaline phosphatase conjugate 
(Sigma-Aldrich) or goat anti-mouse IgG alkaline phosphatase 
conjugate as secondary antibodies.
 Preparation of Live Cells and GEM Particles for the Binding 
Assay 
 Live cells for the binding assay were prepared from 1-ml cul-
tures ( L. salivarius  IBB3154 and  L. lactis  IL1403) with an absor-
bance of about 1.0 at OD 600 nm . Cells were collected by centrifu-
gation and washed once with a 0.5 volume of phosphate-buff-
ered saline (PBS) (58 m M Na 2 HPO 4 , 2H 2 O, 17 m M Na 2 H 2 PO 4 , 
H 2 O, 68 m M NaCl, pH 7.2). GEM particles were obtained via 
chemical pretreatment with 10% TCA (0.6  M ). This method is 
commonly used for peptidoglycan purification from cell wall ex-
tracts. Briefly, bacterial cells from 1-ml cultures ( L. salivarius 
 IBB3154 and  L. lactis  IL1403) with an absorbance of about 1.0 
at OD 600 nm were collected by centrifugation and washed once 
with a 0.5 volume of PBS. Next, the washed cells were resus-
pended in 200 μl of a 10% TCA solution and boiled for 30 min 
[Bosma et al., 2006]. Then, the GEM particles were washed 3 
times with PBS. For protein binding, the prepared live cells and 
GEM particles were resuspended in MRS mixed with 1,000 pmol 
of recombinant protein (CjaA, CjaD, CjaALysM, or CjaDLysM) 
and incubated 60 min. Binding of the proteins to live LAB cells 
or GEM particles was analyzed by immunofluorescence and 
Western blot assays.
 Binding Assays by Immunofluorescence and Western Blot 
Analysis 
 For the immunofluorescence assay,  L. salivarius  IBB3154 and 
L. lactis  IL1403 cells and GEM particles that were mixed with pro-
tein were washed 3 times with 1×  PBS and then resuspended in 
4% (weight/volume) paraformaldehyde and incubated for 10 min 
at room temperature. Next, cells were washed with 1× PBS and 
resuspended in PBS containing 3% bovine serum albumin. After 
30 min of incubation, primary rabbit anti-rCjaA or anti-rCjaD 
antibodies were added at a dilution of 1: 100, followed by addi-
tional incubation for 60 min at room temperature. Then the cells 
were washed 3 times with 1× PBS and resuspended in PBS con-
taining 1% Tween 20. The cells were washed 3 more times with 1× 
PBS and then incubated for 1 h at room temperature with 100 μl 
of PBS containing 3% bovine serum albumin and the secondary 
anti-rabbit antibody Alexa fluor A488 diluted 1: 100. Next, the 
cells were washed 3 times with 1× PBS and resuspended in 50 μl 
of PBS. A 10-μl aliquot of the suspension was spread onto a cham-
ber slide precoated with poly- L -lysine. This was followed by 
mounting in an antifading agent (fluorescence mounting medi-
um; Dako). Fluorescence was visualized using a Nikon A1R MP 
microscope.
 For the Western blot assay, GEM particles made from  L. sali-
varius or live cells of  L. salivarius  were incubated with recombinant 
proteins for 1 h under gentle agitation at 37  °  C. Subsequently, they 
were centrifuged and the supernatants were retained for analysis. 
Next, the cells with bound proteins were washed 3 times with PBS 
and then resuspended in PBS for analysis. The supernatant and the 
cells were mixed with 4× SDS loading-dye and boiled. The proteins 
derived from equal amounts of culture extracts were analyzed by 
Western blot using polyclonal anti-rCjaA or anti-rCjaD serum 
[Łaniewski et al., 2012; Pawelec et al., 2000].
 Results and Discussion 
 Characterization of L. salivarius Strains 
 The aim of this work was to generate an LAB surface 
display system for  C. jejuni antigens. We used 2 LAB 
strains:  L. lactis , the LAB model microorganism tested 
as a mucosal delivery vector for therapeutic proteins 
and vaccines, and  L. salivarius. The  Lactobacillus genus 
has served as a delivery vector of heterologous antigens 
for mucosal immunization, and the genus has added 
 advantages over  Lactoccocus: lactobacilli can persist 
longer than lactococci in the digestive tract and some 
strains have probiotic properties [Turner et al., 2004]. 
The  L.   salivarius  IBB3154 strain was isolated from 
chicken stool samples on MRS agar medium. Macro-
scopic and microscopic (see online suppl. fig. S1; for all 
online  suppl. material, see www.kager.com/doi/10.1159/ 
000368780) observations suggested that this isolated 
strain belonged to the genus  Lactobacillus. The strain 
grew as white colonies on MRS agar medium (online 
suppl. fig. S1A) and formed short rods that could be 
clearly seen by phase contrast microscopy (online suppl. 
fig. S1B). The morphological and microscopic observa-
tions were confirmed by molecular identification: am-
plification of an intergenic chromosomal DNA region 
between the 16S rDNA and 23S rDNA using the genus-
specific primer pairs 16-1A and 23-1B [Tannock et al., 
1999]. This approach generated 2 polymerase chain re-
action (PCR) products of 500 and 700 bp (online suppl. 
fig. S2) which are characteristic of strains belonging to 
the genus  Lactobacillus. This indicated that the strain 
belonged to the genus  Lactobacillus. To identify the spe-
cies of the IBB 3154 strain, the 16S rDNA gene was am-
plified using 343F and 1406 primers (online suppl. fig. 
S3). A PCR product of the expected size, i.e. 1 kb, was 
generated in amounts sufficient for DNA sequencing 
using the same 2 primers. The nucleotide sequence of 
this 16S rDNA PCR product was analyzed using BLAST 
against the nucleotide database on the NCBI website. 
The analysis revealed the highest identity, i.e. 99%, to 
the nucleotide sequence of the 16S rDNA gene of  L. sal-
ivarius  IBB3154 (GeneBank CP002034.1), thus identify-
ing the taxonomic position of the strain as  L. salivarius 
 IBB3154. Because this  L. salivarius  IBB3154 strain was 
isolated from a chicken’s digestive track, we speculate 
that it is able to colonize the chicken intestine. Using 
live  Lactobacillus might facilitate vaccination proce-
dures and lower the cost of immunization. However, 
because the efficacy of immunization is often dependent 
on, among others factors, the amount of antigen deliv-
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ered, GEM particles might be more effective than live 
cells. Thus, in this work we evaluated the possibility of 
employing  L. salivarius GEM particles as a platform to 
present  C. jejuni antigens.
 C. jejuni Antigens Bind to LAB Cells via the 
LysM-Mediated Surface Display System 
 A crucial factor that determines the efficacy of subunit 
vaccines is the selection of antigen(s). As many  Campylo-
bacter strains can colonize the chicken at one time and 
because of the enormous genetic diversity observed among 
 Campylobacter isolates, the potential vaccine candidate 
protein should be conserved among different pathogen se-
rotypes/genotypes to induce cross-protection. To evaluate 
the potential of  L. salivarius GEM particles as a delivery 
vector for  C. jejuni antigens, we chose 2 immunodomi-
nant proteins: CjaA (Cj0982c in the genome of  C. jejuni 
NCTC11168) and CjaD (Cj0113 in the genome of  C. je-
juni NCTC11168). CjaD is a peptidoglycan-associated 
protein (PAL) anchored in the outer membrane [Go-
dlewska et al., 2009]. CjaA is the cysteine-binding protein 
components of the ABC transport system [Muller et al., 
2005; Wyszyńska et al., 2004, 2008]. It participates in the 
in vivo colonization process as the expression levels of the 
 cjaA gene increase when bacterial cultures are grown in 
media that is deficient in iron or on solid media [Holmes 
et al., 2005]. Additionally, CjaA is more abundant in the 
proteome of clinical  Campylobacter isolates compared to 
the proteome of the laboratory strain, and it is recognized 
by chicken maternal antibodies [Cordwell et al., 2008; 
Shoaf-Sweeney et al., 2008]. We analyzed the LAB cell 
wall-binding ability of recombinant proteins containing 
 C. jejuni antigens (CjaA or CjaD) that were fused with the 
PA binding domain of the  L. lactis peptidoglycan hydro-
lase AcmA, which contains 3 lysine motifs (LysM). For 
this purpose, 2 recombinant plasmids expressing fused 
proteins were constructed ( fig. 1 a). To facilitate purifica-
tion of the recombinant proteins, the hybrid proteins also 
contained a 6His tag at their N-terminus. The fused pro-
teins 6HisxCjaAx3LysM (hereinafter referred to as 
CjaALysM) and 6HisxCjaDx3LysM (hereinafter referred 
to as CjaDLysM) were produced using an  Escherichia coli 
expression system and purified by affinity chromatogra-
phy. Western blot analysis with specific rabbit anti-CjaA/
 Fig. 1. Construction and purification of the hybrid proteins which 
consist of  Campylobacter antigens fused to the C-domain of  L. lac-
tis  AcmA.  a Schematic diagram of the genes encoding the hybrid 
proteins 6HisxCjaAx3LysM or 6HisxCjaDx3LysM. Hatching box-
es indicate the LysM repeat sequences.  b ,  c Western blot analysis 
of the CjaALysM produced in the  E. coli Rosetta (DE3) LysS strain 
by autoinduction.  d ,  e Western blot analysis of the CjaDLysM pro-
duced in the  E. coli  (DE3) BL21 strain by IPTG induction. The ar-
rows indicate the position of the CjaALysM ( b ,  c ) or CjaDLysM 
( d ,  e ) fused proteins. The protein extracts from collected fractions 
(equal volumes of fractions were loaded per lane) were separated 
using 12% SDS-PAGE under reducing conditions and probed 
with: anti-CjaA antibodies ( b ), anti-CjaD antibodies ( d ), or anti-
His antibodies ( c ,  e ). Lanes: 1 – cell extract before induction, in-
soluble fraction; 2 – cell extract before induction, soluble fraction; 
3 – cell extract after 24 h of induction, insoluble fraction, 4 – cell 
extract after 24 h of induction, soluble fraction, and M – protein 
molecular-weight marker. 
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anti-CjaD and anti-His antibodies confirmed their speci-
ficity ( fig. 1 b–e). Both hybrid proteins were tested for the 
ability to bind to nontreated or TCA-pretreated  L. sali-
varius cells. CjaA and CjaD proteins, which were also ob-
tained using an  E. coli expression system and purified by 
affinity chromatography, were employed as negative con-
trols in these assays. The binding was examined by confo-
cal microscopy assay using specific anti-CjaA or anti-
CjaD rabbit antibodies and a secondary fluorescent don-
key anti-rabbit IgG conjugated with Alexa fluor 488. We 
examined the ability of hybrid proteins to bind to an 
 L.  salivarius  IBB3154 strain isolated from a chicken intes-
tinal tract.  L. lactis  IL1403 was used as a control. The re-
sults are given in  figure 2 and online supplementary figure 
S4 (control experiments). We found that the binding ef-
ficiency was greater for TCA-pretreated cells (GEM par-
ticles) than for live, untreated cells regardless of the strains 
used. Binding to untreated cells was restricted to specific 
locations on the cell surface, which is consistent with data 
published by others [Bosma et al., 2006; Hu et al., 2010], 
while the hybrid proteins were able to bind to the entire 
surface of the GEM particles. Control experiments lacking 
any added proteins or employing nonfused CjaA or CjaD 
proteins documented the specificity of the used sera and 
showed that generally binding is LysM dependent (online 
suppl. fig. S4) (more than 90% of the cells showed stain-
ing). As the CjaD protein is a peptidoglycan-associated 
protein, it also binds to peptidoglycan. In the case of GEM 
particles, binding was also observed for nonfused CjaA 
protein. However the process is not as intense as in the 
case of CjaALysM protein.
 The LysM-Mediated Binding System Allows the 
Construction of GEM Particles that Present Two 
C. jejuni Antigens 
 To shed more light on the binding process and to 
clearly define whether the binding capability is dependent 
on the structure of the  Campylobacter antigen, we decid-
ed to evaluate the binding efficiency of the recombinant 
proteins by Western blot. As GEM particles bound more 
protein than live cells, we mainly concentrated on exper-
iments employing GEM particles. GEM particles were 
separated from the supernatant by centrifugation and the 
amount of hybrid proteins on the surface of the GEM par-
ticles and in the supernatant was determined. Control 
samples contained CjaA or CjaD protein. The results are 
given in  figure 3 . This experiment confirmed that hybrid 
proteins are able to bind to GEM particles, whereas con-
trol proteins (CjaA or CjaD) that lack the LysM domain 
remain free in the supernatant, especially CjaA ( fig. 3 a, 
 Fig. 2. Localization of CjaALysM and CjaDLysM on  L. lactis  and 
 L. salivarius  cells.  a Localization of the CjaALysM fusion protein 
on nonpretreated  L. lactis  and  L. salivarius  cells.  b Localization of 
the CjaALysM fusion protein on TCA-pretreated  L. lactis  and 
 L. salivarius  cells.  c Localization of the CjaDLysM fusion protein 
on nonpretreated  L. lactis  and  L. salivarius  cells.  d Localization of 
the CjaDLysM fusion protein on TCA-pretreated  L. lactis  and 
 L. salivarius  cells. Scale bar = 2 μm. The data generated from con-
trol experiments are given in online suppl. figure S4. 
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lane 5). This effect is less pronounced for CjaD. Probably 
CjaD, a peptidoglycan-binding protein, can also stimu-
late binding to GEM particles. The result is consistent 
with the data obtained by confocal microscopy assay. The 
strong binding efficiency of CjaDLysM was also observed 
with the  L. salivarius live strain (online suppl. fig. S5). We 
also found that the CjaALysM present in the supernatant 
was subject to extensive degradation ( fig. 3 a, lane 4). We 
concluded that the process is stimulated by the PA do-
main of the fused protein, as it is not correctly localized.
 It is generally accepted that successful chicken immu-
nization against  Campylobacter  colonization should con-
sist of several protective antigens or their epitopes deliv-
ered by an appropriate vector. Thus we decided to deter-
mine whether GEM particles can be used as a platform to 
present both the CjaA and CjaD antigens together as a 
potential divalent vaccine. We suspected that CjaDLysM, 
having a stronger ability to bind to cell wall peptidoglycan 
than CjaALysM, might remove CjaALysM from the GEM 
surface. To analyze the problem, GEM particles were re-
acted with the 2 purified hybrid proteins mixed in equal 
amounts. After binding, GEM particles were collected by 
centrifugation and washed, and the binding efficiency 
was determined by SDS-PAGE and immunoblotting. The 
results are given in  figure 4 . We found that although a 
noticeable amount of CjaALysM stayed in the superna-
tant, a significant amount of the fusion was also bound to 
the GEM surface. Thus we concluded that even though 
 Fig. 3. Analysis of CjaALysM and CjaA ( a ) and CjaDLysM and 
CjaD ( b ) binding to GEM particles by Western blot using poly-
clonal anti-CjaA or anti-CjaD rabbit antibodies and anti-rabbit 
IgG alkaline phosphatase conjugate (Sigma-Aldrich) antibodies. 
GEM were mixed with chimeric proteins (CjaALysM or CjaD-
LysM) or with proteins lacking the LysM domain (CjaA or CjaD). 
Samples were prepared by boiling in 4× SDS loading dye. Proteins 
were resolved by 12% SDS-PAGE, transferred onto nitrocellulose, 
and probed with antibodies. Lanes 1–3 contain equal amounts of 
GEM particles mixed with: 1  – fusion protein; 2  –  protein without 
LysM, and 3 – control, no recombinant protein. Lanes 4–6 contain 
equal amounts of supernatant fractions obtained after removing 
GEM particles by centrifugation. GEM mixed with: 4 – fusion pro-
tein; 5  –  protein without LysM; 6 – control, no recombinant pro-
tein, and M – protein molecular-weight marker. 
 Fig. 4. Simultaneous binding of CjaALysM and CjaDLysM to GEM 
particles determined by Western-blot with anti-CjaD ( a ) and anti-
CjaA rabbit antibodies ( b ). Recombinant CjaA and CjaD that are 
not fused to LysM were used as a control. GEM were mixed with 
CjaALysM and CjaDLysM or with CjaA and CjaD. Samples were 
prepared by boiling in 4× SDS loading dye. Proteins were resolved 
by 12% SDS-PAGE, transferred onto nitrocellulose, and probed 
with antibodies. Lanes 1–3 contain equal amounts of GEM parti-
cles mixed with: 1  –  CjaALysM and CjaDLysM; 2  –  CjaA and CjaD, 
and 3 – control, no recombinant protein. Lanes 4–6 contain equal 
amounts of supernatant fractions obtained after centrifugation of 
GEM particles mixed with: 4  –  CjaALysM and CjaDLysM; 5 – CjaA 
and CjaD; 6 – control, no recombinant protein, and M  – protein 
molecular-weight marker. 
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CjaDLysM has a higher binding efficiency than CjaALysM 
it does not block CjaALysM binding.
 In conclusion, this study demonstrates the potential 
use of LAB GEM particles to deliver  Campylobacter anti-
gens. Our results clearly indicate that GEM can be used 
as delivery vehicles for more than one antigen, and GEM 
may represent a good mucosal delivery tool for future ap-
plications in different chicken diseases.
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